Kidswell Bio Corporation (4584.T)
JPY 102.0
(-7.27%)
JPY 102.0
(-7.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 875.65 Million JPY | 37.83% |
| 2022 | 635.31 Million JPY | -35.75% |
| 2021 | 988.81 Million JPY | 119.37% |
| 2020 | 450.75 Million JPY | 77.28% |
| 2019 | 254.26 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.28 Billion JPY | 46.22% |
| 2023 Q1 | 1.12 Billion JPY | 77.41% |
| 2023 Q4 | 875.65 Million JPY | -34.52% |
| 2023 Q3 | 1.33 Billion JPY | 43.73% |
| 2023 Q2 | 930.5 Million JPY | -17.44% |
| 2023 FY | 875.65 Million JPY | 37.83% |
| 2022 Q2 | 718.27 Million JPY | 0.0% |
| 2022 FY | 635.31 Million JPY | -35.75% |
| 2022 Q4 | 635.31 Million JPY | -11.9% |
| 2022 Q3 | 721.11 Million JPY | 0.39% |
| 2021 FY | 988.81 Million JPY | 119.37% |
| 2020 FY | 450.75 Million JPY | 77.28% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -28.205% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -4784.009% |
| GNI Group Ltd. | 2.33 Billion JPY | 62.428% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 60.692% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -1197.63% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 21.877% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -745.765% |
| AnGes, Inc. | 1.61 Billion JPY | 45.807% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -1083.332% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 69.836% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -172.016% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -475798.913% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -524.842% |
| CanBas Co., Ltd. | 728 Thousand JPY | -120182.143% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -896.613% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -491.902% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -1265.926% |
| PeptiDream Inc. | 2.4 Billion JPY | 63.577% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -16291.876% |
| Ribomic Inc. | 2.27 Million JPY | -38407.212% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -87565399900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -2332.372% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -2919.497% |
| CellSource Co., Ltd. | 305.92 Million JPY | -186.232% |
| FunPep Company Limited | 25.54 Million JPY | -3328.425% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -140.527% |
| Stella Pharma Corporation | 1.11 Billion JPY | 21.554% |
| TMS Co., Ltd. | 50.02 Million JPY | -1650.433% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -4089.532% |
| Cuorips Inc. | 1.04 Million JPY | -83855.321% |
| K Pharma,Inc. | 10.79 Million JPY | -8012.414% |
| Takara Bio Inc. | 11.85 Billion JPY | 92.611% |
| ReproCELL Incorporated | 248.14 Million JPY | -252.887% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -94.336% |
| StemCell Institute Inc. | 42.26 Million JPY | -1971.965% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -283.109% |
| CellSeed Inc. | 46.19 Million JPY | -1795.724% |